chemicals
Jump to
28 Results Found
  • Excel Consolidated June 2020 Net Sales at Rs 133.46 crore, down 29.55% Y-o-Y Aug 14, 2020 11:55 AM IST

    Excel Consolidated June 2020 Net Sales at Rs 133.46 crore, down 29.55% Y-o-Y

  • Excel Standalone June 2020 Net Sales at Rs 133.46 crore, down 29.55% Y-o-Y Aug 14, 2020 11:44 AM IST

    Excel Standalone June 2020 Net Sales at Rs 133.46 crore, down 29.55% Y-o-Y

  • Navin Fluorine Standalone June 2020 Net Sales at Rs 204.74 crore, down 15.32% Y-o-Y Jul 29, 2020 10:45 PM IST

    Navin Fluorine Standalone June 2020 Net Sales at Rs 204.74 crore, down 15.32% Y-o-Y

  • Navin Fluorine Consolidated June 2020 Net Sales at Rs 214.95 crore, down 14.55% Y-o-Y Jul 29, 2020 10:45 PM IST

    Navin Fluorine Consolidated June 2020 Net Sales at Rs 214.95 crore, down 14.55% Y-o-Y

  • PI Industries : A good show in tough times Jun 09, 2020 11:26 AM IST

    PI Industries : A good show in tough times

  • Ideas for Profit | Bodal Chemicals: Poor Q3, but well-positioned to benefit from Chinese shutdowns Feb 14, 2020 08:47 AM IST

    Ideas for Profit | Bodal Chemicals: Poor Q3, but well-positioned to benefit from Chinese shutdowns

  • 3-Point Analysis | Tata Chemicals Q3 review - what investors should do Feb 07, 2020 04:42 PM IST

    3-Point Analysis | Tata Chemicals Q3 review - what investors should do

    Moneycontrol’s Sakshi Batra, does 3-Point Analysis to understand the key earnings fineprint and the outlook on the company.

  • US, China trade smileys – Equity risk premium now takes a back seat Jan 16, 2020 03:49 PM IST

    US, China trade smileys – Equity risk premium now takes a back seat

  • Food colour companies flash green Dec 16, 2019 10:24 AM IST

    Food colour companies flash green

  • Pharma department moves to wrestle NPPA’s special powers to cap drug prices Sep 10, 2017 10:12 AM IST

    Pharma department moves to wrestle NPPA’s special powers to cap drug prices

    In simple terms, Paragraph 19 of the DPCO allows the pricing authority to fix or revise the ceiling price or retail price of any drug which it deems necessary for the interest of the public in case of any extraordinary circumstances.

  • Expect double-digit growth in India: BASF Mar 14, 2017 09:17 PM IST

    Expect double-digit growth in India: BASF

    From dyes to plastics to foam, possibly anything that you use in your day-to-day life has something to do with the chemicals that the global chemical giant, BASF makes. In this episode, Archana Shukla is in conversation with Martin Brudermuller, VC & CTO, BASF.

  • Compulsive traders, stay nimble footed Feb 01, 2017 08:08 AM IST

    Compulsive traders, stay nimble footed

    If you are a compulsive trader do whatever you want to do before 11:00 am and then sit and enjoy, watch the Budget and depending on what announcements FM makes on sector like agri, chemicals, fertilisers some of these have run-up already.

  • Growth can't be taken for granted: Gujarat Alkalies MD Jan 30, 2017 09:45 AM IST

    Growth can't be taken for granted: Gujarat Alkalies MD

    Speaking to CNBC-TV18, Prem Kumar Gera, Managing Director of Gujarat Alkalies & Chemicals, posted a 229.53 percent increase in net profit in Q3 despite huge competition in the business.

  • GNFC hopeful of keeping same level of growth in 2nd half of FY17 Nov 11, 2016 01:46 PM IST

    GNFC hopeful of keeping same level of growth in 2nd half of FY17

    In an interview with CNBC-TV18, Rajiv Kumar Gupta, MD of the company, said in the second quarter of this fiscal year the company declared a profit of Rs 228 crore. This is the highest-ever single profit declared by the company since its inception in 1982.

  • It is buy-on-dips market; global jitters temporary: Sundaram MF Oct 14, 2016 05:15 PM IST

    It is buy-on-dips market; global jitters temporary: Sundaram MF

    Broad changes are happening in global macros. Uncertainty surrounding global events like talks of easing by central banks and strengthening of commodities has led to sell-off by foreign investors, says S Krishna Kumar of Sundaram Mutual Fund.

  • Even midcap IT companies aren't exciting: Dipan Mehta Oct 10, 2016 07:41 PM IST

    Even midcap IT companies aren't exciting: Dipan Mehta

    Dipan Mehta, Member, BSE & NSE said that he is bearish on IT stocks. He says costs are increasing because of Visa overheads for IT companies. Margins are under pressure, he added. Even midcaps, barring the likes of Persistent Systems, aren‘t exciting, he says.

  • Do not need money for capex over next 2-3 yrs: Advanced Enzyme Sep 16, 2016 12:16 PM IST

    Do not need money for capex over next 2-3 yrs: Advanced Enzyme

    Do not need any money for capex over next two-three years, says CL Rathi, MD of Advanced Enzyme Technologies.

  • Expect 15-20% growth for the next 2-3 years: Trident Ltd Aug 09, 2016 11:46 AM IST

    Expect 15-20% growth for the next 2-3 years: Trident Ltd

    Net profit increased 26 percent to Rs 78.45 crore year-on-year (YoY) and EBITDA rose 24 percent to Rs 247 crore (YoY).

  • China chemicals slowdown to benefit biz: Meghmani Mar 31, 2016 01:12 PM IST

    China chemicals slowdown to benefit biz: Meghmani

    In an interview with CNBC-TV18, Natu Patel, MD of Meghmani Organics, discussed the recent slowdown in the Chinese speciality chemicals market and what it means for Indian companies such as his.

  • How India can boost its distressed agriculture sector Apr 25, 2015 03:30 PM IST

    How India can boost its distressed agriculture sector

    Agriculture, as a percent of GDP, has fallen from 30 percent in 1990 to 18 percent now but the number of people depending on the sector hasn't fallen at the same rate. In a CNBC-TV18 interview, experts dissected what is wrong with the sector.

  • Expect to hold EBITDA margins going forward: Atul Jan 23, 2015 05:21 PM IST

    Expect to hold EBITDA margins going forward: Atul

    In an interview with CNBC-TV18, CFO Gopi Kanna talked about the results and the outlook going forward.

  • Rs 200cr QIP funds to be used for expansion: Deepak Nitrite Jan 23, 2015 02:57 PM IST

    Rs 200cr QIP funds to be used for expansion: Deepak Nitrite

    During the company‘s earnings declaration, Deepak Nitrite announced that its board had approved raising of Rs 200 crore through a qualified institutional placement (QIP) issue.

  • Current net debt stands at Rs 325 crore: Sequent Scientific Dec 12, 2014 01:49 PM IST

    Current net debt stands at Rs 325 crore: Sequent Scientific

    Watch the interview of Manish Gupta, CEO, Sequent Scientific with Sumaira Abidi and Reema Tendulkar on CNBC-TV18, in which he spoke about the specialty chemicals business and how they are planning to utilise the profit that was recorded in Q2.

  • D&B Business Expectations Survey: Bad news all around Jul 05, 2013 01:41 PM IST

    D&B Business Expectations Survey: Bad news all around

    All six indices, including volume of sales, selling prices, new orders, inventory, employees and profits, have declined and three of the six indices are at a four quarter low and the fourth index is at a 14 months low. So it is bad news all around unfortunately

  • SP Tulsian's multibagger picks: Deepak Nitrite, HOEC Mar 08, 2013 11:10 AM IST

    SP Tulsian's multibagger picks: Deepak Nitrite, HOEC

    In an interview with CNBC-TV18, SP Tulsian of sptulsian.com picks Deepak Nitrite and Hindustan Oil Exploration Company (HOEC) as his multibaggers. He expects Deepak Nitrite to touch Rs 320 and HOEC Rs 85 in the next twelve months

Sections